Skip to main content
. 2003 Jun 15;36(12):1523–1532. doi: 10.1086/375069

Figure 2.

Figure 2

Change from baseline value in total cold symptom severity scores among picornavirus-infected subjects, days 1–6. Pleconaril recipients experienced significant (P > .05) reductions from baseline by day 2 of treatment in each study.